1ly2
From Proteopedia
(New page: 200px<br /> <applet load="1ly2" size="450" color="white" frame="true" align="right" spinBox="true" caption="1ly2, resolution 1.80Å" /> '''Crystal structure o...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1ly2. | + | [[Image:1ly2.jpg|left|200px]]<br /><applet load="1ly2" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="1ly2" size=" | + | |
caption="1ly2, resolution 1.80Å" /> | caption="1ly2, resolution 1.80Å" /> | ||
'''Crystal structure of unliganded human CD21 SCR1-SCR2 (Complement receptor type 2)'''<br /> | '''Crystal structure of unliganded human CD21 SCR1-SCR2 (Complement receptor type 2)'''<br /> | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1LY2 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NAG as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 1LY2 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NAG:'>NAG</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1LY2 OCA]. |
==Reference== | ==Reference== | ||
| Line 24: | Line 23: | ||
[[Category: complement receptor; epstein barr virus; regulator of complement activation; short consensus repeat; viral receptor; complement control protein]] | [[Category: complement receptor; epstein barr virus; regulator of complement activation; short consensus repeat; viral receptor; complement control protein]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:21:09 2008'' |
Revision as of 14:21, 15 February 2008
|
Crystal structure of unliganded human CD21 SCR1-SCR2 (Complement receptor type 2)
Contents |
Overview
Human complement receptor type 2 (CD21) is the cellular receptor for, Epstein-Barr virus (EBV), a human tumor virus. The N-terminal two short, consensus repeats (SCR1-SCR2) of the receptor interact with the EBV, glycoprotein gp350/220 and also with the natural CD21 ligand C3d. Here we, present the crystal structure of the CD21 SCR1-SCR2 fragment in the, absence of ligand and demonstrate that it is able to bind EBV. Based on a, functional analysis of wild-type and mutant CD21 and molecular modeling, we identify a likely region for EBV attachment and demonstrate that this, region is not involved in the interaction with C3d. A comparison with the, previously determined structure of CD21 SCR1-SCR2 in complex with C3d, shows that, in both cases, CD21 assumes compact V-shaped conformations., However, our analysis reveals a surprising degree of flexibility at the, SCR1-SCR2 interface, suggesting interactions between the two domains are, not specific. We present evidence that the V-shaped conformation is, induced by deglycosylation of the protein, and that physiologic, glycosylation of CD21 would result in a more extended conformation, perhaps with additional epitopes for C3d binding.
Disease
Known diseases associated with this structure: Systemic lupus erythematosus, susceptibility to, 9 OMIM:[120650]
About this Structure
1LY2 is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.
Reference
The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding., Prota AE, Sage DR, Stehle T, Fingeroth JD, Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10641-6. Epub 2002 Jul 16. PMID:12122212
Page seeded by OCA on Fri Feb 15 16:21:09 2008
